Navigation Links
Coherus Announces Initiation Of Phase 3 Trial Of CHS-0214 (Investigational Etanercept Biosimilar) In Chronic Plaque Psoriasis (RaPsOdy)
Date:7/16/2014

lective goals to develop and deliver high quality biologic alternatives that address patient needs," said Ludwig Hantson, Ph.D., president of Baxter BioScience. 

About CHS-0214

CHS-0214 is a proposed biosimilar of etanercept (Enbrel®).  This product was evaluated in a Phase 1 single dose cross-over study in healthy volunteers.  In this trial, CHS-0214 met the primary bioequivalence endpoint of clinical PK similarity to Enbrel®, demonstrating a 98% geometric mean between CHS-0214 and Enbrel®.  No clinically meaningful differences in other safety parameters were observed during this study.

About Coherus BioSciences, Inc.

Coherus is a late-stage clinical biologics platform company focused on the global biosimilar market.  Headquartered in the San Francisco Bay Area and composed of a team of industry veterans with decades of experience in pioneering biologics companies, Coherus has developed an innovative business model that leverages a strategically aligned consortium of key service providers specifically crafted to address the biosimilar opportunity and to achieve competitive scale.  Coherus' commercialization partnerships include global pharmaceutical companies in Europe, Asia and Latin America.

Biosimilars are intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases, with the potential to reduce costs and expand patient access.  For additional information, please visit www.coherus.com.

About Baxter International, Inc.

Baxter International, Inc., through its subsidiaries, develops, manufactures, and markets products that save and sustain the lives of people with hemophilia, immune disorders, cancer, infectious diseases, kidney disease,
'/>"/>

SOURCE Coherus BioSciences, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Coherus Announces CHS-0214 (Proposed Etanercept Biosimilar) Meets Primary Endpoint In Pivotal Pharmacokinetic Clinical Study
2. Coherus anuncia que CHS-0214 (biosimilar etanercept propuesto) supera punto final primario en decisivo estudio clínico farmacocinético
3. Coherus Biosciences als Präsentator zur J.P. Morgan Annual Healthcare Conference 2014 eingeladen
4. Coherus Biosciences Invited to Present at 2014 J.P. Morgan Annual Healthcare Conference
5. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
6. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
7. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
8. Misonix Announces New Distribution Agreement For Panama
9. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
10. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
11. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... 1, 2015 Agena Bioscience TM today announced ... , a commercial and financial hub from which many biotech ... testing laboratories in mainland China . ... Bioscience,s global sales with almost sixty MassARRAY ® Systems ... will allow us to expand our reach and foster ...
(Date:9/1/2015)... TAIPEI , Sept. 1, 2015 ... 2,500 employees, SHL Group has rapidly reached 3,000 ... yet rapid growth in the injectable drug delivery ... A global leader in the design ... SHL offers innovative designs, robust manufacturing capabilities, a ...
(Date:9/1/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/rd9jbr/introduction_to ... "Introduction to Veterinary Pharmacovigilance (London, UK - September ... This course has been designed to provide ... concerned with Veterinary Pharmacovigilance. New entrants, support staff ... better understanding of veterinay drug safety will benefit ...
Breaking Medicine Technology:Agena Bioscience Opens Office in Shanghai, China 2SHL Group Reaches Major Milestone of 3000 Employees 2Introduction to Veterinary Pharmacovigilance Seminar (London, UK - September 23-24) 2
(Date:9/1/2015)... ... ... With former IBMers among its founding members, Inmar has known the value ... years ago. A pilot program begun by the company in 2014 has proved popular ... on pursuing careers in these fields. The program is now open to area middle ...
(Date:9/1/2015)... York (PRWEB) , ... September 01, 2015 , ... Zecurion, ... Zlock Mac , its groundbreaking new version of endpoint DLP developed specifically for Mac ... Mac, in which more than 100 IT and information security professionals had participated. The ...
(Date:9/1/2015)... ... September 01, 2015 , ... Agriculture innovation, urban farming, local food access, and ... be discussed at Seedstock’s 4th Annual Sustainable Agriculture Conference : “Innovation and the ... , In addition to keynotes Pierre Sleiman, founder and CEO of Go Green Agriculture, ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... the 2015-2016 Distinguished Nurse Scholar-in Residence at the Institute of Medicine (IOM) of ... of Biomedical Informatics at Columbia University School of Nursing. A member of the ...
(Date:9/1/2015)... ... 01, 2015 , ... The PracticeMatch Career Fair ... the Marriott Indianapolis Downtown, 350 West Maryland Street, Indianapolis, IN 46225. More than ... the country. All specialties will be represented. Attendees will enjoy free hors d’oeuvres ...
Breaking Medicine News(10 mins):Health News:Inmar Announces Program to Fuel Student Passion for STEM – with an Unconventional Twist 2Health News:Zecurion Announces Endpoint Security for Mac 2Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 2Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 3Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 4Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 5Health News:Columbia Nursing’s Suzanne Bakken Named Distinguished Institute of Medicine Nurse Scholar-in-Residence 2Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 2Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 3Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 4
... Quarter Revenue up 29% to $50.4 Million Strong ... Full Year Revenue Growth of 17% to ... Feb. 28 Cardiac Science,Corporation (Nasdaq: CSCX ), ... informatics products, today announced,record results for the fourth quarter ...
... Robert Leonard, Founder and,Chief Surgeon of Leonard Hair Transplant ... the availability of a new genetic test for male,pattern ... New England to,offer this to patients., Dr. Robert ... be,affected by genetic male pattern baldness. This exciting new ...
... of the patent office "non-final" decision on a human ... Foundation (WARF),shows the following gains made for researchers:, ... was underserved,and new amended claims have been narrowed., ... no matter how,they are derived, but the amended "non-final" ...
... of two cellular receptors that likely contribute to the genesis ... targeted therapies against the disease, says a team led by ... , The finding also helps explain how daily use of ... at bay. , "These two receptors, called EP2 and EP4, ...
... Their U.S. Representative if they Support,Administration,s Medicare Cuts, ... to,begin debate on the Bush Administration,s proposed FY ... nursing home benefit,a new national survey conducted by ... finds 63 percent of likely voters oppose the,cut ...
... Missouri scientist Kattesh Katti recently discovered how to ... water. Kattis research has garnered attention worldwide and ... several disciplines. , Gold nanoparticles are tiny pieces ... by the naked eye. Researchers believe gold nanoparticles ...
Cached Medicine News:Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 2Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 3Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 4Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 5Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 6Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 7Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 8Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 9Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 10Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 11Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 12Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 13Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 14Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 15Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 16Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 17Health News:Dr. Robert Leonard First in New England to Offer Genetic Test for Male Pattern Baldness 2Health News:Closer Analysis Shows Consumer Groups Make Gains in Stem Cell Patent Challenges Against WARF; Appeal Still Planned Against Narrowed Claims 2Health News:Weill Cornell team identifies potential new drug targets against hormone-dependent breast cancer 2Health News:Weill Cornell team identifies potential new drug targets against hormone-dependent breast cancer 3Health News:New National Poll: Majority of American Voters Oppose Bush Administration's Proposed Cuts to Medicare 2Health News:Breakthroughs in nanotechnology on edge of 'knowledge frontier' 2Health News:Breakthroughs in nanotechnology on edge of 'knowledge frontier' 3
Smith & Nephew ACUFEX scissors are constructed without pins for maximum strength, dependability, durability, and safety.,A wide range of tips and angles enable the surgeon to effectively dissect any ...
These backbiters enable simple access to the anterior horn of the meniscus....
The narrow shaft and compact jaw design facilitates access and use in tight spaces, particularly useful in the posterior aspect of the knee....
... Arthrotek® Precision Hand Instruments were developed in ... feel, while still having an instrument with ... without the fear of the bending or ... and manufactured to conform to the surgeon's ...
Medicine Products: